Physician profile
Kiran Sachdev
NPI 1518064120
$734.44
in general payments reported to CMS, 2019-2025
11 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2024: $218 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $323.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $148.01 | 2024 | Dupixent |
| Cook Medical LLC | $105.79 | 2025 | Hemospray |
| Covidien LP | $91.88 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $91.84 | 2019-2024 | Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $86.00 | 2019 | |
| Abbvie INC. | $64.71 | 2019 | |
| Janssen Biotech, INC. | $56.22 | 2019 | |
| Medtronic, INC. | $47.00 | 2024 | Manoscan |
| Ucb, INC. | $15.84 | 2019 | |
| Ironwood Pharmaceuticals, INC | $15.83 | 2019 | |
| Shionogi INC | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kiran Sachdev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.